Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 USD | +2.59% | -5.54% | +598.32% |
05-31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ELEVATION ONCOLOGY, INC. | Bio Therapeutic Drugs | +2.04% | -5.54% | +598.32% | +41.51% | - | 201M |
- Stock Market
- Equities
- ELEV Stock
- Charts Elevation Oncology, Inc.
- Relative Strength Chart